The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice
The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Abstract
To test whether the hypothesis that the Alzheimer's A beta peptide is neurotoxic, we introduced a transgene into mice to direct expression of this peptide to neurons. We show that the transgene is expressed in brain regions which are severely affected in Alzheimer's disease resulting in extensive neuronal degeneration. Morphological and biochemical evidence indicates that the eventual death of these cells occurs by apoptosis. Coincident with the cell degeneration and cell death is the presence of a striking reactive gliosis. Over 50% of the transgenic mice die by 12 months of age, half the normal life span of control mice. These data show that A beta is neurotoxic in vivo and suggest that apoptosis may be responsible for the accompanying neuronal loss, the principal underlying cellular feature of Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While evidence for extracellular Aβ deposition was scarce, neuronal Aβ immunoreactivity was detected in the cortex and hippocampus, resulting in abundant neurodegeneration, with biochemical and morphological evidence for an apoptotic mechanism [61].”
From Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models (2020) · cites this paper as [61]
In the citing paper
“Efficient secretion of Aβ from the BRI fusion protein distinguishes this approach from studies using Aβ minigene constructs that generate high levels of intracellular Aβ and minimal secreted Aβ (LaFerla et al., 1995).”
From Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice (2005) · cites this paper as LaFerla et al., 1995
In the citing paper
“However, none of these studies prove or disprove a role of intracellular Aβ in AD pathogenesis.”
From Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice (2005) · cites this paper as LaFerla et al., 1995
In the citing paper
“Previous studies with transgenic mice expressing Aβ minigenes that are not efficiently secreted suggest that intracellular Aβ can be neurotoxic (LaFerla et al., 1995), as do studies of direct injection of aggregated Aβ into cultured primary neurons (Zhang et al., 2002).”
From Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice (2005) · cites this paper as LaFerla et al., 1995
In the citing paper
“lack of plaque formation in intraneuronal Aβ42 accumulating transgenic mice with concomitant neurodegeneration [36, 93] limited conclusions that could be drawn to the human disease, since pathological diagnosis of AD requires Aβ plaques.”
From Intraneuronal β-amyloid accumulation and synapse pathology in Alzheimer’s disease (2010) · cites this paper as [93]
Citations
Cites
1 retracted
Kawabata, S., Higgins, G. A., & Gordon, J. W. (1991) · Nature · doi:10.1038/354476a0 · Cited by 108
RetractedIdentification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(84)80190-4 · Cited by 5,404
Kozak, M. (1986) · Cell · doi:10.1016/0092-8674(86)90762-2 · Cited by 4,741
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992) · Nature · doi:10.1038/360672a0 · Cited by 1,757
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731
Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., et al. (1992) · Science · doi:10.1126/science.1439760 · Cited by 1,447
Research works printed but not linked: 2
- Wyllie, A.H. Cell death. Int. Rev. Cytol. S17, 755–785 (1987).
- Kim, K.S. et al. Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci. Res. Comm. 2, 121–130 (1988).
Cited by
Items 101–200 of 511
Esler, W. P., Stimson, E. R., Ghilardi, J. R., Lu, Y.-A., Felix, A. M., Vinters, H. V., Mantyh, P. W., Lee, J. P., & Maggio, J. E. (1996) · Biochemistry · doi:10.1021/bi961302+ · Cited by 158
The Genetics of the Amyloidoses
Buxbaum, J. N., & Tagoe, C. E. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.543 · Cited by 173
Flavonoid‐mediated presenilin‐1 phosphorylation reduces Alzheimer's disease β‐amyloid production
Rezai‐Zadeh, K., Douglas Shytle, R., Bai, Y., Tian, J., Hou, H., Mori, T., Zeng, J., Obregon, D., Town, T., & Tan, J. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00344.x · Cited by 153
Aβ as a bioflocculant: implications for the amyloid hypothesis of Alzheimer’s disease
Robinson, S. R., & Bishop, G. M. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00342-6 · Cited by 173
Davies, C., & Tournier, C. (2012) · Biochemical Society Transactions · doi:10.1042/bst20110641 · Cited by 152
Reaume, A. G., Howland, D. S., Trusko, S. P., Savage, M. J., Lang, D. M., Greenberg, B. D., Siman, R., & Scott, R. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.38.23380 · Cited by 150
Redox Regulation of the Intrinsic Pathway in Neuronal Apoptosis
Franklin, J. L. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3596 · Cited by 150
Pratt, B. M., & McPherson, J. M. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00018-x · Cited by 166
Rohn, T. T., Vyas, V., Hernandez-Estrada, T., Nichol, K. E., Christie, L.-A., & Head, E. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5620-07.2008 · Cited by 146
“In addition, PCR amplification was performed using published primer sequences for human tau and APP for 3xTg-AD mice (LaFerla et al., 1995; Sugarman et al., 2002).”
Neuroinflammation and anti-inflammatory therapy for Alzheimer’s disease
Moore, A. H., & O’Banion, M. K. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00162-x · Cited by 172
β-Amyloid Mediated Nitration of Manganese Superoxide Dismutase
Muthuswamy, A., Tangpong, J., Keller, J. N., Murphy, M. P., Markesbery, W. R., Kiningham, K. K., & Clair, D. K. S. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051223 · Cited by 157
Amyloid-β in Alzheimer Disease: The Null versus the Alternate Hypotheses
Lee, H., Zhu, X., Castellani, R. J., Nunomura, A., Perry, G. L., & Smith, M. A. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.114009 · Cited by 157
Tienari, P. J., Ida, N., Ikonen, E., Simons, M., Weidemann, A., Multhaup, G., Masters, C. L., Dotti, C. G., & Beyreuther, K. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4125 · Cited by 139
Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease
Pugh, P. L., Richardson, J. C., Bate, S. T., Upton, N., & Sunter, D. C. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.11.044 · Cited by 153
Zhang, Y. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0913-04.2004 · Cited by 138
Sun, X.-Y., Wei, Y.-P., Xiong, Y., Wang, X.-C., Xie, A.-J., Wang, X.-L., Yang, Y., Wang, Q., Lu, Y.-M., Liu, R., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.309070 · Cited by 136
Peptidergic transmission: From morphological correlates to functional implications
Zupanc, G. K. H. (1996) · Micron · doi:10.1016/0968-4328(95)00028-3 · Cited by 151
DNA polymerase β deficiency leads to neurodegeneration and exacerbates Alzheimer disease phenotypes
Sykora, P., Misiak, M., Wang, Y., Ghosh, S., Leandro, G. S., Liu, D., Tian, J., Baptiste, B. A., Cong, W.-N., Brenerman, B. M., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1356 · Cited by 136
Beeri, R., Andres, C. R., Lev-Lehman, E., Timberg, R., Huberman, T., Shani, M., & Soreq, H. (1995) · Current Biology · doi:10.1016/s0960-9822(95)00211-9 · Cited by 140
Tseng, B. P., Esler, W. P., Clish, C. B., Stimson, E. R., Ghilardi, J. R., Vinters, H. V., Mantyh, P. W., Lee, J. P., & Maggio, J. E. (1999) · Biochemistry · doi:10.1021/bi990718v · Cited by 119
Kar, S., Seto, D., Gaudreau, P., & Quirion, R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-03-01034.1996 · Cited by 132
Seizures in Alzheimer’s disease
Born, H. A. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.11.051 · Cited by 144
Pathophysiology of Alzheimer's Disease
Imbimbo, B. P., Lombard, J., & Pomara, N. (2005) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.09.009 · Cited by 154
Requirement of the Familial Alzheimer's Disease Gene PS2 for Apoptosis
Vito, P., Wolozin, B., Ganjei, J. K., Iwasaki, K., Lacaná, E., & D'Adamio, L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31025 · Cited by 131
Alzheimer‐associated presenilin‐2 confers increased sensitivity to poptosis in PC12 cells
Deng, G., Pike, C. J., & Cotman, C. W. (1996) · FEBS Letters · doi:10.1016/s0014-5793(96)01142-8 · Cited by 131
Yan, S. D., & Stern, D. M. (2005) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2005.00427.x · Cited by 129
Rodent models of Alzheimer's disease: Rat aβ infusion approaches to amyloid deposits
Frautschy, S. A., Yang, F., Calderón, L., & Cole, G. M. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02073-x · Cited by 125
Chin, J., & Scharfman, H. E. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2012.11.040 · Cited by 123
The role of innate immunity in Alzheimer's disease
Ennerfelt, H. E., & Lukens, J. R. (2020) · Immunological Reviews · doi:10.1111/imr.12896 · Cited by 119
Transgenic mice expressing Alzheimer amyloid precursor proteins
Hsiao, K. (1998) · Experimental Gerontology · doi:10.1016/s0531-5565(98)00045-x · Cited by 137
Apoptosis in the Nervous System: Morphological Features, Methods, Pathology, and Prevention.
LO, A. C., HOUENOU, L. J., & OPPENHEIM, R. W. (1995) · Archives of Histology and Cytology · doi:10.1679/aohc.58.139 · Cited by 119
Internalization of β-Amyloid Peptide by Primary Neurons in the Absence of Apolipoprotein E
Saavedra, L., Mohamed, A., Ma, V., Kar, S., & de Chaves, E. P. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701823200 · Cited by 118
Only amyloidogenic intermediates of transthyretin induce apoptosis
Andersson, K., Olofsson, A., Nielsen, E. H., Svehag, S., & Lundgren, E. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00465-5 · Cited by 139
Janicki, S., & Monteiro, M. J. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.2.485 · Cited by 118
Caspase Gene Expression in the Brain as a Function of the Clinical Progression of Alzheimer Disease
Pompl, P. N., Yemul, S., Xiang, Z., Ho, L., Haroutunian, V., Purohit, D., Mohs, R., & Pasinetti, G. M. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.369 · Cited by 117
The role of intracellular amyloid β in Alzheimer's disease
Li, M., Chen, L., Lee, D. H. S., Yu, L., & Zhang, Y. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.08.002 · Cited by 135
Neurobehavioral characterization of APP23 transgenic mice with the SHIRPA primary screen
Lalonde, R., Dumont, M., Staufenbiel, M., & Strazielle, C. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.06.020 · Cited by 130
Extracellular deposition of beta-amyloid upon p53-dependent neuronal cell death in transgenic mice.
LaFerla, F. M., Hall, C. K., Ngo, L., & Jay, G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118957 · Cited by 114
Self-citationMonte, S. M., Ghanbari, K., Frey, W. H., Beheshti, I., Averback, P., Hauser, S. L., Ghanbari, H. A., & Wands, J. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119864 · Cited by 114
Magrané, J., Rosen, K. M., Smith, R. C., Walsh, K., Gouras, G. K., & Querfurth, H. W. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1723-05.2005 · Cited by 113
Neuron Loss in Transgenic Mouse Models of Alzheimer's Disease
Wirths, O., & Bayer, T. A. (2010) · International Journal of Alzheimer's Disease · doi:10.4061/2010/723782 · Cited by 111
Apoptosis — Molecular mechanisms and biomedical implications
McConkey, D. J., Zhivotovsky, B., & Orrenius, S. (1996) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(95)00006-2 · Cited by 119
Kumar-Singh, S., Dewachter, I., Moechars, D., Lübke, U., De Jonghe, C., Ceuterick, C., Checler, F., Naidu, A., Cordell, B., Cras, P., et al. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.1999.0272 · Cited by 107
Synaptic transmission block by presynaptic injection of oligomeric amyloid beta
Moreno, H., Yu, E., Pigino, G., Hernandez, A. I., Kim, N., Moreira, J. E., Sugimori, M., & Llinás, R. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900944106 · Cited by 107
Neuronal Network Oscillations in Neurodegenerative Diseases
Nimmrich, V., Draguhn, A., & Axmacher, N. (2015) · NeuroMolecular Medicine · doi:10.1007/s12017-015-8355-9 · Cited by 122
Sugarman, M. C., Yamasaki, T. R., Oddo, S., Echegoyen, J. C., Murphy, M. P., Golde, T. E., Jannatipour, M., Leissring, M. A., & LaFerla, F. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082545599 · Cited by 105
Self-citationFujita, T., & Palmieri, G. M. A. (2000) · Journal of Bone and Mineral Metabolism · doi:10.1007/s007740050101 · Cited by 105
Patel, T. B. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.3.4 · Cited by 124
Wang, H.-Y., Stucky, A., Liu, J., Shen, C., Trocme-Thibierge, C., & Morain, P. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.6088-08.2009 · Cited by 102
Tarus, B., Straub, J. E., & Thirumalai, D. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.11.022 · Cited by 111
Possible Causes of Alzheimer's Disease: Amyloid Fragments, Free Radicals, and Calcium Homeostasis
Hölscher, C. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0193 · Cited by 102
Transgenic mouse models of Alzheimer’s disease
Janus, C., Chishti, M. A., & Westaway, D. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00033-8 · Cited by 101
Mastrangelo, M. A., Sudol, K. L., Narrow, W. C., & Bowers, W. J. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.090059 · Cited by 100
Winton, M. J., Lee, E. B., Sun, E., Wong, M. M., Leight, S., Zhang, B., Trojanowski, J. Q., & Lee, V. M.-Y. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6637-10.2011 · Cited by 100
RetractedEckert, A., Steiner, B., Marques, C., Leutz, S., Romig, H., Haass, C., & Müller, W. E. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1064 · Cited by 100
Beeri, R., Le Novère, N., Mervis, R., Huberman, T., Grauer, E., Changeux, J. P., & Soreq, H. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69062441.x · Cited by 99
Galbete, J. L., Martin, T. R., PERESSINI, E., Modena, P., Bianchi, R., & Forloni, G. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3480307 · Cited by 98
Animal models of cerebral β-amyloid angiopathy
Walker, L. C. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00017-9 · Cited by 110
Zhang, L., Zhao, B., Yew, D. T. W., Kusiak, J. W., & Roth, G. S. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6698 · Cited by 102
Corbett, B. F., Leiser, S. C., Ling, H.-P., Nagy, R., Breysse, N., Zhang, X., Hazra, A., Brown, J. T., Randall, A. D., Wood, A., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2325-12.2013 · Cited by 97
Zhao, M., Su, J., Head, E., & Cotman, C. W. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.07.006 · Cited by 97
Mechanisms of amyloid plaque pathogenesis
Fiala, J. C. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0284-8 · Cited by 113
Caspase cleavage of members of the amyloid precursor family of proteins
Galvan, V., Chen, S., Lu, D., Logvinova, A., Goldsmith, P., Koo, E. H., & Bredesen, D. E. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00970.x · Cited by 96
Zhang, W., Wang, P., Sha, H., Ni, J., Li, M., & Gu, G.-J. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8640-x · Cited by 103
Disentangling Mitochondria in Alzheimer’s Disease
Johri, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111520 · Cited by 108
Aging sensitizes toward ROS formation and lipid peroxidation in PS1M146L transgenic mice
Schüssel, K., Frey, C., Jourdan, C., Keil, U., Weber, C. C., Müller-Spahn, F., Müller, W. E., & Eckert, A. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.10.041 · Cited by 100
G protein βγ complex‐mediated apoptosis by familial Alzheimer's disease mutant of APP
Giambarella, U., Yamatsuji, T., Okamoto, T., Matsui, T., Ikezu, T., Murayama, Y., Levine, M. A., Katz, A., Gautam, N., & Nishimoto, I. (1997) · The EMBO Journal · doi:10.1093/emboj/16.16.4897 · Cited by 102
Down Syndrome and Dementia: Seizures and Cognitive Decline
Lott, I. T., Doran, E., Nguyen, V. Q., Tournay, A., Movsesyan, N., & Gillen, D. L. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-111613 · Cited by 93
Murine models of brain aging and age-related neurodegenerative diseases
Jucker, M., & Ingram, D. K. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(96)02243-7 · Cited by 101
Cribbs, D. H., Azizeh, B. Y., Cotman, C. W., & LaFerla, F. M. (2000) · Biochemistry · doi:10.1021/bi000029f · Cited by 92
Self-citationNi, B., Wu, X., Du, Y., Su, Y., Hamilton-Byrd, E., Rockey, P. K., Rosteck Jr., P., Poirier, G. G., & Paul, S. M. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-05-01561.1997 · Cited by 93
Sawmiller, D., Habib, A., Li, S., Darlington, D., Hou, H., Tian, J., Shytle, R. D., Smith, A., Giunta, B., Mori, T., et al. (2016) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2016.08.018 · Cited by 91
Formation of Apoptosis‐Inducing Amyloid Fibrils by Tryptophan
Shaham‐Niv, S., Rehak, P. L., Vuković, L., Adler‐Abramovich, L., Král, P., & Gazit, E. (2016) · Israel Journal of Chemistry · doi:10.1002/ijch.201600076 · Cited by 90
Berger-Sweeney, J. E., McPhie, D. L., Arters, J., Greenan, J., Oster‐Granite, M. L., & Neve, R. L. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00014-5 · Cited by 98
Rodrigues, C. M. P., Solá, S., Brito, M. A., Brondino, C. D., Brites, D. M. T. O., & Moura, J. J. G. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4370 · Cited by 98
A β Internalization by Neurons and Glia
Mohamed, A., & Posse de Chaves, E. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/127984 · Cited by 90
Strack, S., Zaucha, J. A., Ebner, F. F., Colbran, R. J., & Wadzinski, B. E. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980323)392:4<515::aid-cne8>3.0.co;2-3 · Cited by 203
Cytotoxicity of Insulin within its Self-assembly and Amyloidogenic Pathways
Grudzielanek, S., Velkova, A., Shukla, A. K., Smirnovas, V., Tatarek‐Nossol, M., Rehage, H., Kapurniotu, A., & Winter, R. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.04.053 · Cited by 92
Amyloid-β Oligomers May Impair SNARE-Mediated Exocytosis by Direct Binding to Syntaxin 1a
Yang, Y., Kim, J., Kim, H. Y., Ryoo, N., Lee, S., Kim, Y., Rhim, H., & Shin, Y.-K. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.07.044 · Cited by 88
“…are strongly suspected to influence the progression of AD, diverse pathological roles of the aggregated protein in the synapse have been reported (Benilova et al., 2012; Haass and Selkoe, 2007; Hardy, 2009; LaFerla et al., 1995; McLean et al., 1999; Puzzo et al., 2008; Shankar et al., 2008).”
BackgroundAzizeh, B. Y., Cribbs, D. H., Cotman, C. W., & LaFerla, F. M. (2006) · American Peptide Symposia · doi:10.1007/0-306-46881-6_287 · Cited by 88
Self-citationAll-D-Enantiomers of β-Amyloid Exhibit Similar Biological Properties to All-L-β-Amyloids
Cribbs, D. H., Pike, C. J., Weinstein, S. L., Velazquez, P., & Cotman, C. W. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.7431 · Cited by 88
Marshall, K., Daniel, S. E., Cairns, N. J., Jenner, P. G., & Halliwell, B. B. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7604 · Cited by 89
Molecular and clinical aspects of apoptosis
Uren, A. G., & Vaux, D. L. (1996) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00098-8 · Cited by 87
Glial responses to steroids as markers of brain aging
Nichols, N. R. (1999) · Journal of Neurobiology · doi:10.1002/(sici)1097-4695(19990915)40:4<585::aid-neu13>3.0.co;2-1 · Cited by 83
Hölscher, C. (2005) · Reviews in the Neurosciences · doi:10.1515/revneuro.2005.16.3.181 · Cited by 82
Processing of Amyloid Precursor Protein in Human Primary Neuron and Astrocyte Cultures
LeBlanc, A. C., Papadopoulos, M., Bélair, C., Chu, W., Crosato, M., Powell, J., & Goodyer, C. G. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68031183.x · Cited by 74
The state versus amyloid-β: the trial of the most wanted criminal in Alzheimer disease
Rottkamp, C. A., Atwood, C., Joseph, J. A., Nunomura, A., Perry, G. L., & Smith, M. A. (2002) · Peptides · doi:10.1016/s0196-9781(02)00069-4 · Cited by 87
Pfundstein, G., Nikonenko, A. G., & Sytnyk, V. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.969547 · Cited by 97
Nuclear Translocation Uncovers the Amyloid Peptide Aβ42 as a Regulator of Gene Transcription*
Barucker, C., Harmeier, A., Weiske, J., Fauler, B., Albring, K. F., Prokop, S., Hildebrand, P., Lurz, R., Heppner, F. L., Huber, O., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.564690 · Cited by 79
Protection against amyloid beta cytotoxicity by sulforaphane: Role of the proteasome
Park, H.-M., Kim, J., & Kwak, M. (2009) · Archives of Pharmacal Research · doi:10.1007/s12272-009-1124-2 · Cited by 88
McGinley, L. M., Sims, E., Lunn, J. S., Kashlan, O. N., Chen, K. S., Bruno, E. S., Pacut, C. M., Hazel, T., Johe, K., Sakowski, S. A., et al. (2016) · Stem Cells Translational Medicine · doi:10.5966/sctm.2015-0103 · Cited by 76
Cathepsin D displays in vitro β-secretase-like specificity
Chevallier, N., Vizzavona, J., Marambaud, P., Baur, C.-P., Spillantini, M. G., Fulcrand, P., Martínez, J., Goedert, M., Vincent, J., & Checler, F. (1997) · Brain Research · doi:10.1016/s0006-8993(96)01330-3 · Cited by 87
Death and survival of neuronal cells exposed to Alzheimer's insults
Niikura, T., Hashimoto, Y., Tajima, H., & Nishimoto, I. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10354 · Cited by 76
LaFerla, F. M., Sugarman, M. C., Lane, T. E., & Leissring, M. A. (2000) · Journal of Molecular Neuroscience · doi:10.1385/jmn:15:1:45 · Cited by 78
Self-citationNeuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models
Wirths, O., & Zampar, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218144 · Cited by 75
“While evidence for extracellular Aβ deposition was scarce, neuronal Aβ immunoreactivity was detected in the cortex and hippocampus, resulting in abundant neurodegeneration, with biochemical and morphological evidence for an apoptotic mechanism [61].”
BackgroundCiccone, R., Franco, C., Piccialli, I., Boscia, F., Casamassa, A., de Rosa, V., Cepparulo, P., Cataldi, M., Annunziato, L., & Pannaccione, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-50018-1 · Cited by 74
Apoptotic neurons in Alzheimer's disease frequently show intracellular Aβ42 labeling
Chui, D. H., Dobo, E., Makifuchi, T., Akiyama, H., Kawakatsu, S., Petit, A., Checler, F., Araki, W., Takahashi, K., & Tabira, T. (2001) · Journal of Alzheimer's Disease · doi:10.3233/jad-2001-3208 · Cited by 74
Schmitz, A., Schneider, A., Kummer, M. P., & Herzog, V. (2004) · Traffic · doi:10.1111/j.1600-0854.2004.00159.x · Cited by 74
Cerebrovascular Pathology Contributes to the Heterogeneity of Alzheimer's Disease
Etiene, D., Kraft, J., Ganju, N., Gomez-Isla, T., Gemelli, B., Hyman, B. T., Hedley-Whyte, E. T., Wands, J. R., & de la Monte, S. M. (1998) · Journal of Alzheimer’s Disease · doi:10.3233/jad-1998-1205 · Cited by 74
Aluminum-induced apoptosis in cultured astrocytes and its effect on calcium homeostasis
Guo, G., & Liang, Y. (2001) · Brain Research · doi:10.1016/s0006-8993(00)03057-2 · Cited by 74
Metadata
- Authors
- LaFerla, F. M., Tinkle, B. T., Bieberich, C. J., Haudenschild, C. C., & Jay, G.
- Venue
- Nature Genetics
- Published
- 1995-01
- Volume
- 9
- Issue
- 1
- Pages
- 21-30
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1992484817
- Cited by
- 513
- References
- 69
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 7 · 2021: 8 · 2020: 11 · 2019: 12 · 2018: 5 · 2017: 7 · 2016: 11 · 2015: 16 · 2014: 13 · 2013: 9 · 2012: 13
- FWCI
- 34.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- Alzheimer's disease, amyloid-beta, neurotoxicity, neuronal apoptosis, neurodegeneration, reactive gliosis, transgenic mice, neuronal loss
- MeSH terms
- Alzheimer Disease, Animals, Base Sequence, Gliosis, Humans, Mice, Transgenic, Molecular Sequence Data, Nerve Degeneration, DNA Probes, Gene Expression, Amyloid beta-Peptides, Apoptosis, In Situ Hybridization, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.